Although fluoxetine was the first SSRI to be approved and marketed in the United States, it took over seven years of clinical trials (Phase I-Phase III) to do so. Meanwhile, Astra AB introduced zimeldine (Zelmid®), the first SSRI, to the European market in March 1982. However, zimeldine, which was derived from pheniramine, was taken off the European market in September 1983 due to severe side effects such as hypersensitivity reactions and Guillain-Barre syndrome, an acute peripheral neuropathy. The hypersensitivity reactions were similar to a flu-like syndrome and included fever, joint/muscle pain, headaches, and hepatic effects.

A Historical Note on the Development of Zimelidine, the First Selective Serotonin Reuptake Inhibitor

In 1960s, evidence began to emerge suggesting a significant role of serotonin in depression. This led to the development of zimelidine, the first selective serotonin reuptake inhibitor (SSRI). Zimelidine was derived from pheniramine and was marketed in Europe in 1982. However, it was removed from the market in 1983 due to severe side effects such as hypersensitivity reactions and Guillain-Barre syndrome.

Despite its short-lived availability, zimelidine paved the way for the development of other SSRIs such as fluoxetine, which was approved by the FDA in 1987 and launched in the US market in 1988 under the trade name Prozac. The development of SSRIs revolutionized the treatment of depression and other mood disorders, providing a safer and more effective alternative to earlier antidepressants such as the tricyclics and MAO inhibitors.

In addition to conducting a thorough medical history and physical examination, healthcare providers typically order a series of tests to aid in the diagnosis of narcolepsy. These tests may include a multiple sleep latency test (MSLT) and a polysomnogram (PSG). The MSLT measures the time it takes for a person to fall asleep during the day, while the PSG records various physiological parameters during sleep, such as brain waves, eye movements, and muscle activity. These tests can help confirm the presence of narcolepsy and rule out other sleep disorders.

Sleep Disorders

The International Classification of Sleep Disorders (ISCD) categorizes sleep disorders into several main categories and subclasses. Dyssomnias are intrinsic sleep disorders that include narcolepsy, psychopsychologic insomnia, idiopathic hypersomnia, restless leg syndrome, periodic limb movement disorder, and obstructive sleep apnea. Extrinsic sleep disorders include inadequate sleep hygiene and alcohol-dependent sleep disorder. Circadian rhythm disorders consist of jet lag syndrome, shift work sleep disorder, irregular sleep-wake pattern, delayed sleep phase syndrome, and advanced sleep phase disorder. Parasomnias include arousal disorders such as sleepwalking and sleep terrors, sleep-wake transition disorders such as rhythmic movement disorder, sleep talking, and nocturnal leg cramps, and parasomnias associated with REM sleep such as nightmares and sleep paralysis. Sleep disorders associated with medical/psychiatric disorders and proposed sleep disorders are also included in the classification.

Narcolepsy is a disorder of unknown cause that is characterized by excessive sleepiness, cataplexy, and other REM sleep phenomena such as sleep paralysis and hypnagogic hallucinations. Periodic limb movement disorder is characterized by periodic episodes of repetitive and highly stereotyped limb movements that occur during sleep. Restless legs syndrome is a disorder characterized by disagreeable leg sensations that usually occur prior to sleep onset and that cause an almost irresistible urge to move the legs. Jet lag syndrome consists of varying degrees of difficulties in initiating or maintaining sleep, excessive sleepiness, decrements in subjective daytime alertness and performance, and somatic symptoms following rapid travel across multiple time zones. Shift work sleep disorder consists of symptoms of insomnia of excessive sleepiness that occur as transient phenomena in relation to work schedules. Non 24 hour sleep wake syndrome consists of a chronic steady pattern comprising one to two hour daily delays in sleep onset and wake times in an individual living in society. Sleepwalking consists of a series of complex behaviors that are initiated during slow-wave sleep and result in walking during sleep. Sleep terrors are characterized by a sudden arousal from slow wave sleep with a piercing scream of cry, accompanied by autonomic and behavioral manifestations of intense fear. Rhythmic movement disorder comprises a group of stereotyped, repetitive movements involving large muscles, usually of the head and neck. Sleep starts are sudden, brief contractions of the legs, sometimes also involving the arms and head, that occur at sleep onset. Nocturnal leg cramps are painful sensations of muscular tightness of tension, usually in the calf but occasionally in the foot, that occur during the sleep episode. Nightmares are frightening dreams that usually awaken the sleeper from REM sleep. Sleep paralysis is a common condition characterized by transient paralysis of skeletal muscles which occurs when awakening from sleep of less often while falling asleep.

Stigma is a term used to describe the negative attitudes and beliefs that people hold towards individuals who are different from them. There are several types of stigma, including discredited and discreditable stigma, felt stigma, enacted stigma, and courtesy stigma. Discredited stigma refers to visible stigmas such as race, gender, of physical disability, while discreditable stigma refers to concealable stigmas such as mental illness of HIV infection. Felt stigma is the shame and fear of discrimination that prevents people from seeking help, while enacted stigma is the experience of unfair treatment by others. Finally, courtesy stigma refers to the stigma that attaches to those who are associated with a stigmatized person.

Karl Theodor Jaspers, a prominent German psychiatrist and philosopher, made significant contributions to modern psychiatry and philosophy. His book General Psychopathology, published in 1913, introduced many of the diagnostic criteria used today. Jaspers distinguished between primary delusions, which are inexplicable and sudden, and secondary delusions, which can be understood based on the patient’s internal and external environment. Other notable figures in the field include Eugen Bleuler, who coined the term schizophrenia, Emil Kraepelin, who introduced dementia praecox, and Kurt Schneider, who developed the first rank symptoms of schizophrenia.

First Rank Symptoms: Their Significance in Identifying Schizophrenia

First rank symptoms were introduced by Kurt Schneider in 1938 as a practical tool for non-psychiatrists to identify schizophrenia. While they are highly suggestive of schizophrenia, they are not pathognomonic and can also be seen in affective and personality disorders. Additionally, there is no evidence to support their prognostic significance.

A systematic review in 2015 found that first rank symptoms differentiated schizophrenia from nonpsychotic mental health disorders with a sensitivity of 61.8% and a specificity of 94.1%. They also differentiated schizophrenia from other types of psychosis with a sensitivity of 58% and a specificity of 74.7%.

The first rank symptoms include running commentary, thought echo, voices heard arguing, thought insertion, thought withdrawal, thought broadcast, delusional perception, somatic passivity, made affect, and made volition. While they can be helpful in identifying schizophrenia, they should not be relied upon as the sole diagnostic criteria.

According to the 13th edition of Maudsley, asenapine and lurasidone are associated with the lowest risk.

Antipsychotics: Common Side Effects and Relative Adverse Effects

Antipsychotics are medications used to treat various mental health conditions, including schizophrenia and bipolar disorder. However, they can also cause side effects that can be bothersome of even serious. The most common side effects of antipsychotics are listed in the table below, which includes the adverse effects associated with their receptor activity.

Antidopaminergic effects: These effects are related to the medication’s ability to block dopamine receptors in the brain. They can cause galactorrhoea, gynecomastia, menstrual disturbance, lowered sperm count, reduced libido, Parkinsonism, dystonia, akathisia, and tardive dyskinesia.

Anticholinergic effects: These effects are related to the medication’s ability to block acetylcholine receptors in the brain. They can cause dry mouth, blurred vision, urinary retention, and constipation.

Antiadrenergic effects: These effects are related to the medication’s ability to block adrenaline receptors in the body. They can cause postural hypotension and ejaculatory failure.

Histaminergic effects: These effects are related to the medication’s ability to block histamine receptors in the brain. They can cause drowsiness.

The Maudsley Guidelines provide a rough guide to the relative adverse effects of different antipsychotics. The table below summarizes their findings, with +++ indicating a high incidence of adverse effects, ++ indicating a moderate incidence, + indicating a low incidence, and – indicating a very low incidence.

Drug Sedation Weight gain Diabetes EPSE Anticholinergic Postural Hypotension Prolactin elevation
Amisulpride – + + + – – +++
Aripiprazole – +/- – +/- – – –
Asenapine + + +/- +/- – – +/-
Clozapine +++ +++ +++ – +++ +++ –
Flupentixol + ++ + ++ ++ + +++
Fluphenazine + + + +++ ++ + +++
Haloperidol + + +/- +++ + + +++
Olanzapine ++ +++ +++ +/- + + +
Paliperidone + ++ + + + ++ +++
Pimozide + + – + + + +++
Quetiapine ++ ++ ++ – + ++ –
Risperidone + ++ + + + ++ +++
Zuclopenthixol ++ ++ + ++ ++ + +++

Overall, it is important to discuss the potential side effects of antipsychotics with a healthcare provider and to monitor for any adverse effects while taking these medications.

Neo-Freudians were therapists who developed their own theories while still retaining core Freudian components. Some important neo-Freudians include Alfred Adler, Carl Jung, Erik Erickson, Harry Stack Sullivan, Wilfred Bion, John Bowlby, Anna Freud, Otto Kernberg, Margaret Mahler, and Donald Winnicott. Each of these individuals contributed unique ideas to the field of psychology. For example, Carl Jung introduced the concept of the persona and differentiated between the personal and collective unconscious, while Erik Erickson is known for his stages of psychosocial development. Margaret Mahler developed theories on child development, including the three main phases of autistic, symbiotic, and separation-individuation. Donald Winnicott introduced the concept of the transitional object and the good enough mother. Overall, neo-Freudians expanded upon Freud’s ideas and helped to shape modern psychotherapy.

– A Battle’s sign is a physical indication of a basal skull fracture.
– Babinski’s sign is a clinical sign that suggests an upper motor neuron lesion.
– Kernig’s sign is a clinical sign that indicates meningeal irritation.
– Russell’s sign is characterized by scarring on the knuckles and back of the hand, and it is indicative of repeated induced vomiting.

Hoover’s Sign for Differentiating Organic and Functional Weakness

Functional weakness refers to weakness that is inconsistent with any identifiable neurological disease and may be diagnosed as conversion disorder of dissociative motor disorder. To differentiate between organic and functional weakness of pyramidal origin, Dr. Charles Franklin Hoover described Hoover’s sign over 100 years ago.

This test is typically performed on the lower limbs and is useful when the nature of hemiparesis is uncertain. When a person with organic hemiparesis is asked to flex the hip of their normal leg against resistance, they will not exert pressure on the examiner’s hand placed under the heel on the affected side. However, in hysterical weakness, the examiner will feel increased pressure on their hand. Hoover’s sign is a valuable tool for distinguishing between organic and functional weakness.

Primary Afferent Axons: Conveying Information about Touch and Pain

Primary afferent axons play a crucial role in conveying information about touch and pain from the surface of the body to the spinal cord and brain. These axons can be classified into four types based on their functions: A-alpha (proprioception), A-beta (touch), A-delta (pain and temperature), and C (pain, temperature, and itch). While all A axons are myelinated, C fibers are unmyelinated.

A-delta fibers are responsible for the sharp initial pain, while C fibers are responsible for the slow, dull, longer-lasting second pain. Understanding the different types of primary afferent axons and their functions is essential in diagnosing and treating various sensory disorders.

Neurotransmitters are substances used by neurons to communicate with each other and with target tissues. They are synthesized and released from nerve endings into the synaptic cleft, where they bind to receptor proteins in the cellular membrane of the target tissue. Neurotransmitters can be classified into different types, including small molecules (such as acetylcholine, dopamine, norepinephrine, serotonin, and GABA) and large molecules (such as neuropeptides). They can also be classified as excitatory or inhibitory. Receptors can be ionotropic or metabotropic, and the effects of neurotransmitters can be fast of slow. Some important neurotransmitters include acetylcholine, dopamine, GABA, norepinephrine, and serotonin. Each neurotransmitter has a specific synthesis, breakdown, and receptor type. Understanding neurotransmitters is important for understanding the function of the nervous system and for developing treatments for neurological and psychiatric disorders.

The objective is to decrease the occurrence of the conduct through punishment, which involves taking away a pleasurable stimulus (the train set).

Operant Conditioning: Reinforcement, Punishment, and More

Operant conditioning, also known as instrumental learning, is a theory of learning developed by B.F. Skinner. It suggests that people learn by interacting with their environment. Reinforcement and punishment are key concepts in operant conditioning. A reinforcer is a stimulus of event that increases the likelihood of a behavior being repeated. Reinforcement can be positive of negative. Positive reinforcement occurs when a behavior is strengthened by adding a rewarding stimulus, while negative reinforcement occurs when a behavior is strengthened by removing an unpleasant stimulus. A punisher is a stimulus that decreases the likelihood of a behavior being repeated. Positive punishment occurs when a behavior is reduced in frequency by adding an unpleasant stimulus, while negative punishment occurs when a behavior is reduced in frequency by removing a pleasant stimulus.

Primary reinforcers are instinctual desires such as food, water, social approval, and sex. Secondary reinforcers, also known as conditioned reinforcers, are not innately appreciated and people have to learn to like them through classical conditioning of other methods. Secondary reinforcers include things such as money. Different patterns of reinforcement have different influences on the response. There are five main reinforcement schedules: fixed interval, variable interval, fixed ratio, variable ratio, and random. Variable ratio schedules are most resistant to extinction.

Shaping and chaining are techniques used when an exact behavior cannot be performed and so cannot be rewarded. Shaping involves rewarding successive, increasingly accurate approximations to the behavior, while chaining involves breaking a complex task into smaller, more manageable sections. Escape conditioning refers to a situation whereby an aversive situation is removed after a response. It is a form of negative reinforcement. Habituation refers to the phenomenon whereby there is a decrease in response to a stimulus over time. Covert sensitization is a technique used whereby someone learns to use mental imagery to associate a behavior with a negative consequence.

Buspirone is a type of anti-anxiety medication that belongs to the azapirone (azaspirodecanedione) class of drugs. It is used to treat the same conditions as benzodiazepines. Unlike benzodiazepines, buspirone is a partial agonist of the serotonin 5HT1A receptor and does not cause sedation, physical dependence, of psychomotor impairment. However, it may cause side effects such as dizziness, headache, excitement, and nausea. Other less common side effects include dry mouth, tachycardia/palpitations/chest pain, drowsiness/confusion, seizures, fatigue, and sweating. Buspirone is not recommended for individuals with epilepsy, severe hepatic impairment, moderate to severe renal impairment, during pregnancy, of while breastfeeding.

The PANSS scale is a commonly utilized tool in schizophrenia research to assess both positive and negative symptoms. The BDI measures depression using the Beck inventory, while the Calgary scale is specifically designed to rate depression in individuals with schizophrenia. CIWA is a scale used to evaluate the severity of alcohol withdrawal, and LUNSER is a rating scale for neuroleptic side effects developed by Liverpool University.

Edinburgh Postnatal Depression Scale (EPDS)

The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire designed to screen for postnatal depression in primary care settings. It should only be used to assess a women’s mood over the past seven days and cannot be used to diagnose depression. The EPDS excludes some symptoms common in the perinatal period, such as tiredness and irritability, as they do not differentiate between depressed and non-depressed postnatal women. Women are asked to select one of four responses that most closely represents how they have felt over the past seven days. Scores for the 10 items are added together, with a score of 0-9 indicating a low likelihood of depression, 10-12 indicating a moderate likelihood, and 13 of more indicating a high likelihood. The statements include feelings of happiness, sadness, anxiety, and thoughts of self-harm.

Freud’s Structural Theory: Understanding the Three Areas of the Mind

According to Freud’s structural model, the human mind is divided into three distinct areas: the Id, the Ego, and the Superego. The Id is the part of the mind that contains instinctive drives and operates on the ‘pleasure principle’. It functions without a sense of time and is governed by ‘primary process thinking’. The Ego, on the other hand, attempts to modify the drives from the Id with external reality. It operates on the ‘reality principle’ and has conscious, preconscious, and unconscious aspects. It is also home to the defense mechanisms. Finally, the Superego acts as a critical agency, constantly observing a person’s behavior. Freud believed that it developed from the internalized values of a child’s main caregivers. The Superego contains the ‘ego ideal’, which represents ideal attitudes and behavior. It is often referred to as the conscience. Understanding these three areas of the mind is crucial to understanding Freud’s structural theory.

Agomelatine is an antidepressant that targets 5HT2C, melatonin-1, and melatonin-2 receptors and is approved for treating major depression. Bupropion is not licensed as an antidepressant in the UK but is recommended by NICE for smoking cessation. It has dopaminergic and noradrenergic effects but does not affect melatonin receptors. Escitalopram is an SSRI antidepressant that does not impact melatonin receptors. Melatonin, on the other hand, acts on melatonin receptors but is not an antidepressant; it is used to treat primary insomnia. Vortioxetine is a multimodal antidepressant that enhances serotonin and other neurotransmitter levels in the brain by targeting 5HT3, 7, 1A, and 1B receptors. It is not known to affect melatonin receptors and is not currently licensed for use in the UK.

– Catatonia is a psychiatric syndrome characterized by disturbed motor functions, mood, and thought.
– Key behaviors associated with catatonia include stupor, posturing, waxy flexibility, negativism, automatic obedience, mitmachen, mitgehen, ambitendency, psychological pillow, forced grasping, obstruction, echopraxia, aversion, mannerisms, stereotypies, motor perseveration, echolalia, and logorrhoea.
– These behaviors are often tested in exam questions.
– Karl Ludwig Kahlbaum is credited with the original clinical description of catatonia.

Chlorphenamine, also known as Piriton, is classified as a first-generation antihistamine that functions by obstructing the H1 receptor. This sedative antihistamine is utilized to treat allergic conditions like hay fever. Additionally, it is present in certain cough medicines as it reduces the production of mucus.

MAOIs: A Guide to Mechanism of Action, Adverse Effects, and Dietary Restrictions

First introduced in the 1950s, MAOIs were the first antidepressants introduced. However, they are not the first choice in treating mental health disorders due to several dietary restrictions and safety concerns. They are only a treatment option when all other medications are unsuccessful. MAOIs may be particularly useful in atypical depression (over eating / over sleeping, mood reactivity).

MAOIs block the monoamine oxidase enzyme, which breaks down different types of neurotransmitters from the brain: norepinephrine, serotonin, dopamine, as well as tyramine. There are two types of monoamine oxidase, A and B. The MOA A are mostly distributed in the placenta, gut, and liver, but MOA B is present in the brain, liver, and platelets. Selegiline and rasagiline are irreversible and selective inhibitors of MAO type B, but safinamide is a reversible and selective MAO B inhibitor.

The most common adverse effects of MAOIs occurring early in treatment are orthostatic hypotension, daytime sleepiness, insomnia, and nausea; later common effects include weight gain, muscle pain, myoclonus, paraesthesia, and sexual dysfunction.

Pharmacodynamic interactions with MAOIs can cause two types of problem: serotonin syndrome (mainly due to SSRIs) and elevated blood pressure (caused by indirectly acting sympathomimetic amines releasers, like pseudoephedrine and phenylephrine). The combination of MAOIs and some TCAs appears safe. Only those TCAs with significant serotonin reuptake inhibition (clomipramine and imipramine) are likely to increase the risk of serotonin syndrome.

Tyramine is a monoamine found in various foods, and is an indirect sympathomimetic that can cause a hypertensive reaction in patients receiving MAOI therapy. For this reason, dietary restrictions are required for patients receiving MAOIs. These restrictions include avoiding matured/aged cheese, fermented sausage, improperly stored meat, fava of broad bean pods, and certain drinks such as on-tap beer. Allowed foods include fresh cottage cheese, processed cheese slices, fresh packaged of processed meat, and other alcohol (no more than two bottled or canned beers of two standard glasses of wine, per day).

The trigeminal nerve is responsible for controlling the muscles involved in chewing, while the glossopharyngeal nerves consist of both motor and sensory fibers that originate from nuclei in the medulla oblongata. The motor fibers of the glossopharyngeal nerves stimulate the pharyngeal muscles and parotid gland secretory cells, while the sensory fibers transmit impulses from the posterior third of the tongue, tonsils, and pharynx to the cerebral cortex.

Overview of Cranial Nerves and Their Functions

The cranial nerves are a complex system of nerves that originate from the brain and control various functions of the head and neck. There are twelve cranial nerves, each with a specific function and origin. The following table provides a simplified overview of the cranial nerves, including their origin, skull exit, modality, and functions.

The first cranial nerve, the olfactory nerve, originates from the telencephalon and exits through the cribriform plate. It is a sensory nerve that controls the sense of smell. The second cranial nerve, the optic nerve, originates from the diencephalon and exits through the optic foramen. It is a sensory nerve that controls vision.

The third cranial nerve, the oculomotor nerve, originates from the midbrain and exits through the superior orbital fissure. It is a motor nerve that controls eye movement, pupillary constriction, and lens accommodation. The fourth cranial nerve, the trochlear nerve, also originates from the midbrain and exits through the superior orbital fissure. It is a motor nerve that controls eye movement.

The fifth cranial nerve, the trigeminal nerve, originates from the pons and exits through different foramina depending on the division. It is a mixed nerve that controls chewing and sensation of the anterior 2/3 of the scalp. It also tenses the tympanic membrane to dampen loud noises.

The sixth cranial nerve, the abducens nerve, originates from the pons and exits through the superior orbital fissure. It is a motor nerve that controls eye movement. The seventh cranial nerve, the facial nerve, also originates from the pons and exits through the internal auditory canal. It is a mixed nerve that controls facial expression, taste of the anterior 2/3 of the tongue, and tension on the stapes to dampen loud noises.

The eighth cranial nerve, the vestibulocochlear nerve, originates from the pons and exits through the internal auditory canal. It is a sensory nerve that controls hearing. The ninth cranial nerve, the glossopharyngeal nerve, originates from the medulla and exits through the jugular foramen. It is a mixed nerve that controls taste of the posterior 1/3 of the tongue, elevation of the larynx and pharynx, and swallowing.

The tenth cranial nerve, the vagus nerve, also originates from the medulla and exits through the jugular foramen. It is a mixed nerve that controls swallowing, voice production, and parasympathetic supply to nearly all thoracic and abdominal viscera. The eleventh cranial nerve, the accessory nerve, originates from the medulla and exits through the jugular foramen. It is a motor nerve that controls shoulder shrugging and head turning.

The twelfth cranial nerve, the hypoglossal nerve, originates from the medulla and exits through the hypoglossal canal. It is a motor nerve that controls tongue movement. Overall, the cranial nerves play a crucial role in controlling various functions of the head and neck, and any damage of dysfunction can have significant consequences.

Huntington’s Disease: Genetics and Pathology

Huntington’s disease is a genetic disorder that follows an autosomal dominant pattern of inheritance. It is caused by a mutation in the Huntington gene, which is located on chromosome 4. The mutation involves an abnormal expansion of a trinucleotide repeat sequence (CAG), which leads to the production of a toxic protein that damages brain cells.

The severity of the disease and the age of onset are related to the number of CAG repeats. Normally, the CAG sequence is repeated less than 27 times, but in Huntington’s disease, it is repeated many more times. The disease shows anticipation, meaning that it tends to worsen with each successive generation.

The symptoms of Huntington’s disease typically begin in the third of fourth decade of life, but in rare cases, they can appear in childhood of adolescence. The most common symptoms include involuntary movements (chorea), cognitive decline, and psychiatric disturbances.

The pathological hallmark of Huntington’s disease is the gross bilateral atrophy of the head of the caudate and putamen, which are regions of the brain involved in movement control. The EEG of patients with Huntington’s disease shows a flattened trace, indicating a loss of brain activity.

Macroscopic pathological findings include frontal atrophy, marked atrophy of the caudate and putamen, and enlarged ventricles. Microscopic findings include neuronal loss and gliosis in the cortex, neuronal loss in the striatum, and the presence of inclusion bodies in the neurons of the cortex and striatum.

In conclusion, Huntington’s disease is a devastating genetic disorder that affects the brain and causes a range of motor, cognitive, and psychiatric symptoms. The disease is caused by a mutation in the Huntington gene, which leads to the production of a toxic protein that damages brain cells. The pathological changes in the brain include atrophy of the caudate and putamen, neuronal loss, and the presence of inclusion bodies.

Medications that can exacerbate psoriasis symptoms include:
– Lithium
– Selective serotonin reuptake inhibitors (SSRIs)
– Beta blockers
– Angiotensin-converting enzyme (ACE) inhibitors

Lithium – Pharmacology

Pharmacokinetics:
Lithium salts are rapidly absorbed following oral administration and are almost exclusively excreted by the kidneys unchanged. Blood samples for lithium should be taken 12 hours post-dose.

Ebstein’s:
Ebstein’s anomaly is a congenital malformation consisting of a prolapse of the tricuspid valve into the right ventricle. It occurs in 1:20,000 of the general population. Initial data suggested it was more common in those using lithium but this had not held to be true.

Contraindications:
Addison’s disease, Brugada syndrome, cardiac disease associated with rhythm disorders, clinically significant renal impairment, untreated of untreatable hypothyroidism, low sodium levels.

Side-effects:
Common side effects include nausea, tremor, polyuria/polydipsia, rash/dermatitis, blurred vision, dizziness, decreased appetite, drowsiness, metallic taste, and diarrhea. Side-effects are often dose-related.

Long-term use is associated with hypothyroidism, hyperthyroidism, hypercalcemia/hyperparathyroidism, irreversible nephrogenic diabetes insipidus, and reduced GFR.

Lithium-induced diabetes insipidus:
Treatment options include stopping lithium (if feasible), keeping levels within 0.4-0.8 mmol/L, once-daily dose of the drug taken at bedtime, amiloride, thiazide diuretics, indomethacin, and desmopressin.

Toxicity:
Lithium salts have a narrow therapeutic/toxic ratio. Risk factors for lithium toxicity include drugs altering renal function, decreased circulating volume, infections, fever, decreased oral intake of water, renal insufficiency, and nephrogenic diabetes insipidus. Features of lithium toxicity include GI symptoms and neuro symptoms.

Pre-prescribing:
Before prescribing lithium, renal function, cardiac function, thyroid function, FBC, and BMI should be checked. Women of childbearing age should be advised regarding contraception, and information about toxicity should be provided.

Monitoring:
Lithium blood levels should be checked weekly until stable, and then every 3-6 months once stable. Thyroid and renal function should be checked every 6 months. Patients should be issued with an information booklet, alert card, and record book.

Tricyclic Antidepressants: Uses, Types, and Side-Effects

Tricyclic antidepressants (TCAs) are a type of medication used for depression and neuropathic pain. However, due to their side-effects and toxicity in overdose, they are not commonly used for depression anymore. TCAs can be divided into two types: first generation (tertiary amines) and second generation (secondary amines). The secondary amines have a lower side effect profile and act primarily on noradrenaline, while the tertiary amines boost serotonin and noradrenaline.

Some examples of secondary amines include desipramine, nortriptyline, protriptyline, and amoxapine. Examples of tertiary amines include amitriptyline, lofepramine, imipramine, clomipramine, dosulepin (dothiepin), doxepin, trimipramine, and butriptyline. Common side-effects of TCAs include drowsiness, dry mouth, blurred vision, constipation, and urinary retention.

Low-dose amitriptyline is commonly used for neuropathic pain and prophylaxis of headache. Lofepramine has a lower incidence of toxicity in overdose. However, amitriptyline and dosulepin (dothiepin) are considered the most dangerous in overdose. It is important to consult with a healthcare provider before taking any medication and to follow their instructions carefully.

Active placebos are intentionally designed to induce unpleasant effects, meaning they are not entirely inactive. If the negative side effects are caused by patient-related factors, such as their negative expectations, this is known as the nocebo effect.

Understanding the Placebo Effect

In general, a placebo is an inert substance that has no pharmacological activity but looks, smells, and tastes like the active drug it is compared to. The placebo effect is the observable improvement seen when a patient takes a placebo, which results from patient-related factors such as expectations rather than the placebo itself. Negative effects due to patient-related factors are termed the nocebo effect.

Active placebos are treatments with chemical activity that mimic the side effects of the drug being tested in a clinical trial. They are used to prevent unblinding of the drug versus the placebo control group. Placebos need not always be pharmacological and can be procedural, such as sham electroconvulsive therapy.

The placebo effect is influenced by factors such as the perceived strength of the treatment, the status of the treating professional, and the branding of the compound. The placebo response is greater in mild illness, and the response rate is increasing over time. Placebo response is usually short-lived, and repeated use can lead to a diminished effect, known as placebo sag.

It is difficult to separate placebo effects from spontaneous remission, and patients who enter clinical trials generally do so when acutely unwell, making it challenging to show treatment effects. Breaking the blind may influence the outcome, and the expectancy effect may explain why active placebos are more effective than inert placebos. Overall, understanding the placebo effect is crucial in clinical trials and personalized medicine.

Perception is an active process that involves being aware of and interpreting sensations received through our sensory organs. When we perceive something, we tend to focus on patterns that stand out from their background, such as when we hear our name being mentioned in a crowded room (known as the cocktail party phenomenon). Our brain also tends to group similar items together and perceive interrupted lines as continuous (known as the law of continuity). Additionally, our eyes have the ability to adjust their focus from distant objects to closer ones (known as accommodation), which helps us perceive depth and distance. Pictorial depth, such as in a painting of photograph, can enhance our perception by providing more detailed and realistic visual cues.

Imprinting – A Rapid, Unreinforced, Irreversible Attachment in Animals and Humans

Imprinting is a fascinating phenomenon observed in some animals and humans, where a phase-sensitive attachment is formed towards the first conspicuous object seen after birth of hatching. Konrad Lorenz’s classic experiment with Greylag geese demonstrated that imprinting consists of three stages – following response, attachment development, and sexual preference formation. Imprinting is a rapid process that can occur within minutes, and it does not require any reinforcement to happen. It also occurs during a clearly defined period known as the critical period, and once it happens, it is irreversible.

Imprinting has been observed in various species, including birds, mammals, and even humans. In humans, imprinting can occur during the early stages of life and can influence social and emotional development. For example, infants may develop an attachment towards their primary caregiver, which can shape their future relationships and social interactions.

Overall, imprinting is a fascinating and complex phenomenon that highlights the importance of early experiences in shaping an individual’s behavior and preferences.

Familiarity with neuropsychological scales is necessary for the MRCPsych exams, including knowledge of the purpose of the test, whether it requires a trained observer, and the approximate duration of the test. For example, the Cornell scale assesses depression in dementia, while the Alzheimer’s disease assessment scale (ADAS) consists of eleven sections for cognitive function and ten for non-cognitive functions, taking 45 minutes with a trained observer. The abbreviated mental test score (AMTS) takes three minutes and is scored out of ten, while the clock drawing test takes two minutes and is often used in conjunction with the MMSE as a screening tool for mild-moderate dementia. The MMSE is a widely used scale with a maximum score of 30.

The term PrPSc originated from scrapie, a prion disease that affects sheep. In humans, the normal isoform of prion protein is PrPC, while the abnormal form is known as PrPres (protease-resistant) of PrPSc. Scrapie has been observed in sheep for over 300 years, while BSE in cattle was only identified in the 1980s. Feline spongiform encephalopathy (FSE) is a prion disease that affects cats, and Chronic wasting disease (CWD) is a similar condition that affects deer.

Benzodiazepines and Z-drugs (such as zopiclone and zolpidem) have a common mechanism of action on the GABA receptor. It is noteworthy that alcohol also affects this receptor, which explains the similar effects observed in alcohol and benzodiazepine use. Additionally, benzodiazepines play a role in managing alcohol withdrawal symptoms.

Mechanisms of Action of Different Drugs

Understanding the mechanisms of action of different drugs is crucial for medical professionals. It is a common topic in exams and can earn easy marks if studied well. This article provides a list of drugs and their mechanisms of action in different categories such as antidepressants, anti dementia drugs, mood stabilizers, anxiolytic/hypnotic drugs, antipsychotics, drugs of abuse, and other drugs. For example, mirtazapine is a noradrenaline and serotonin specific antidepressant that works as a 5HT2 antagonist, 5HT3 antagonist, H1 antagonist, alpha 1 and alpha 2 antagonist, and moderate muscarinic antagonist. Similarly, donepezil is a reversible acetylcholinesterase inhibitor used as an anti dementia drug, while valproate is a GABA agonist and NMDA antagonist used as a mood stabilizer. The article also explains the mechanisms of action of drugs such as ketamine, phencyclidine, buprenorphine, naloxone, atomoxetine, varenicline, disulfiram, acamprosate, and sildenafil.

Antipsychotic Medications and Their Forms of Administration

Antipsychotic medications are available in various forms of administration, including oral and long-acting injectable (LAI) forms. Paliperidone, a medication closely related to risperidone, is available in both oral form (Invega) and as a monthly LAI (Xeplion). Amisulpride and zotepine are currently only available in oral form, while asenapine, released in 2012 in the UK, is only available in oral (sublingual/buccal) form. Sertindole, an oral antipsychotic, was withdrawn from the European market for several years in the late 1990s due to concerns about QTc interval prolongation.

Fluoxetine can cause a serotonin syndrome when combined with sumatriptan due to their structural similarity and shared 5HT agonist properties. Agomelatine does not affect serotonin levels. Reboxetine works by inhibiting the reuptake of noradrenaline. To decrease the risk of serotonin syndrome, the dosage of fluoxetine can be reduced by 20 mg. Changing the form of fluoxetine to a liquid form would not significantly alter its bioavailability.